American Heart Association National Integrated ASCVD Initiative: An Implementation Initiative to Improve Lipid Management Among Patients With ASCVD

Affiliations

¹ Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University, Baltimore, MD (C.E.N., S.S.M.).
² Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, CA (A.S.B.).
³ Stanford School of Medicine, Palo Alto, CA (A.S.B).
⁴ Department of Adult Health and Gerontological Nursing, College of Nursing, Rush University Medical Center, Chicago, IL (L.T.B.).
⁵ USC Titus Center for Medication Safety and Population Health, USC Mann School of Pharmacy, Los Angeles, CA (S.C.).
⁶ Lewis Katz School of Medicine, Temple University, Philadelphia, PA (M.T.M.).
⁷ Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.P.S.).
⁸ Heart and Vascular Institute, Titus Regional Medical Center, Mt. Pleasant, TX (S.L.S.).
⁹ Patient-Centered Outcomes Research Institute, Washington, DC (T.Y.-P.W.).
¹⁰ American Heart Association, Dallas, TX (R.A., C.B., H. Hong, S.O.K., K.J.O., K.T.).
¹¹ University of Maryland School of Medicine, Baltimore (H. Haft).

Chiadi E Ndumele et al. Circ Cardiovasc Qual Outcomes. 2025 Aug.

. 2025 Aug;18(8):e011627.

doi: 10.1161/CIRCOUTCOMES.124.011627. Epub 2025 Aug 19.

¹ Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University, Baltimore, MD (C.E.N., S.S.M.).
² Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, CA (A.S.B.).
³ Stanford School of Medicine, Palo Alto, CA (A.S.B).
⁴ Department of Adult Health and Gerontological Nursing, College of Nursing, Rush University Medical Center, Chicago, IL (L.T.B.).
⁵ USC Titus Center for Medication Safety and Population Health, USC Mann School of Pharmacy, Los Angeles, CA (S.C.).
⁶ Lewis Katz School of Medicine, Temple University, Philadelphia, PA (M.T.M.).
⁷ Division of Cardiology and Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.P.S.).
⁸ Heart and Vascular Institute, Titus Regional Medical Center, Mt. Pleasant, TX (S.L.S.).
⁹ Patient-Centered Outcomes Research Institute, Washington, DC (T.Y.-P.W.).
¹⁰ American Heart Association, Dallas, TX (R.A., C.B., H. Hong, S.O.K., K.J.O., K.T.).
¹¹ University of Maryland School of Medicine, Baltimore (H. Haft).

No abstract available

Conflict of interest statement

None.

1. Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149:e347–e913. doi: 10.1161/CIR.0000000000001209 - PMC - PubMed
1. Wilkinson MJ, Lepor NE, Michos ED. Evolving management of low-density lipoprotein cholesterol: a personalized approach to preventing atherosclerotic cardiovascular disease across the risk continuum. J Am Heart Assoc. 2023;12:e028892. doi: 10.1161/JAHA.122.028892 - PMC - PubMed
1. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al. AHA/ACC guideline on the management of blood cholesterol. J Am Coll Cardiol. 2019;73:e285–e350. doi: 10.1016/j.jacc.2018.11.003 - PubMed
1. Nelson AJ, Haynes K, Shambhu S, Eapen Z, Cziraky MJ, Nanna MG, Calvert SB, Gallagher K, Pagidipati NJ, Granger CB. High-intensity statin use among patients with atherosclerosis in the U.S. J Am Coll Cardiol. 2022;79:1802–1813. doi: 10.1016/j.jacc.2022.02.048 - PMC - PubMed
1. Agnello F, Ingala S, Laterra G, Scalia L, Barbanti M. Novel and emerging LDL-C lowering strategies: a new era of dyslipidemia management. J Clin Med. 2024;13:1251. doi: 10.3390/jcm13051251 - PMC - PubMed